Please login to the form below

Not currently logged in


This page shows the latest Zepatier news and features for those working in and with pharma, biotech and healthcare.

Merck & Co joins big pharma pricing pledge – but sceptics unconvinced

Merck & Co joins big pharma pricing pledge – but sceptics unconvinced

Thus while it has pledged a 60% cut to the list price of its hepatitis drug Zepatier, sales of the product are so low that after paying rebates to insurers, the

Latest news

More from news
Approximately 6 fully matching, plus 8 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company Conferences, Events and Exhibition Stands is one of the UK’s leading event and exhibition agencies, specialising in healthcare. We understand your communication goals, whether...

Latest intelligence

Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....